Dr. Amar Agarwal, Athiya Agarwal, Adil Agarwal, Anosh Agarwal,Ashvin Agarwal, Ashar agarwal, Anosh Agarwal, Dr. Agarwal's Eye institute Private Ltd,Dr. Amar Agarwal family trust, Adil agarwal Family trust, Dr. Anosh Agarwal Family trust, Dr. ashwin Agarwal Family Trust, Dr. Ashar Agarwal Family Trust has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
All promoters of Dr. Agarwal's Health Care — six individual promoters (Dr. Amar Agarwal, Athiya Agarwal, Adil Agarwal, Anosh Agarwal, Ashvin Agarwal, Ashar Agarwal), the promoter group entity Dr. Agarwal's Eye Institute (and its Pvt Ltd arm), and five family trusts — have filed a combined annual declaration with BSE and NSE on April 3, 2025. Under Regulation 31(4) of the SEBI Takeover Regulations, each of them confirmed that they have not created any new encumbrance (pledge, lien, or similar charge) on their equity shares in the company during the financial year 2024-25, other than what was already disclosed. This is a routine yearly compliance filing and does not involve any change in shareholding or new financial action.
This is a routine regulatory filing with no material impact on shareholders. It provides mild comfort that promoters have not added new pledging on their holdings during the year, but it does not change ownership, voting power, or the company's fundamentals.